Drug
Krn125
Krn125: highest development phase Phase 2, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KRN125(pegfilgrastim), PLR001(plerixafor) NCT05007652 | Phase 2 | Multiple Myeloma and Malignant Lymphoma |
Latest
No recent events.
Follow Krn125 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.